Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States. The company's platforms include Cerebrum, a small molecule...
16 insider purchases on record · latest filing 2023-10-10.
Insiders have also filed 41 sale transactions at PRAX.